Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer

Abstract Human epidermal growth factor receptor 2 (HER2) gene amplification in circulating tumor cells (CTCs) and disseminated tumor cells (DTCs) might be useful for modifying Herceptin therapy in breast cancer. In the process of investigating the utility of a microfluidic platform for detecting HER...

Cijeli opis

Bibliografski detalji

Glavni autori:	Savitri Krishnamurthy, Farideh Bischoff, Julie Ann Mayer, Karina Wong, Tam Pham, Henry Kuerer, Ashutosh Lodhi, Anirban Bhattacharyya, Carolyn Hall, Anthony Lucci
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2013-04-01
Serija:	Cancer Medicine
Teme:	Breast cancer circulating tumor cells disseminated tumor cells HER2 status minimal residual disease
Online pristup:	https://doi.org/10.1002/cam4.70
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!